Advanced Biomed Inc
Cash Flow Statement
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-3.3M | $-2.8M |
| Depreciation & Amortization | $343.8K | $399.6K |
| Depreciation | $224.8K | $268.3K |
| Amortization | — | — |
| Stock-Based Compensation | — | — |
| Net Cash from Operating Activities | $-5.8M | $-2.1M |
| Investing Activities | ||
| Capital Expenditures | $31.7K | $74.1K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-31.7K | $-74.1K |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $5.9M | $1.9M |
| Net Change in Cash | $295.9K | $-14.3K |
| Free Cash Flow | $-5.9M | $-2.2M |